rs9639393
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001277115.2(DNAH11):āc.7901A>Gā(p.Asn2634Ser) variant causes a missense change. The variant allele was found at a frequency of 0.598 in 1,610,198 control chromosomes in the GnomAD database, including 300,973 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N2634I) has been classified as Benign.
Frequency
Consequence
NM_001277115.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DNAH11 | NM_001277115.2 | c.7901A>G | p.Asn2634Ser | missense_variant | 48/82 | ENST00000409508.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DNAH11 | ENST00000409508.8 | c.7901A>G | p.Asn2634Ser | missense_variant | 48/82 | 5 | NM_001277115.2 | P1 | |
DNAH11 | ENST00000605912.1 | c.461A>G | p.Asn154Ser | missense_variant | 3/4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.503 AC: 76446AN: 151882Hom.: 21691 Cov.: 31
GnomAD3 exomes AF: 0.533 AC: 132060AN: 247692Hom.: 38870 AF XY: 0.547 AC XY: 73530AN XY: 134418
GnomAD4 exome AF: 0.608 AC: 886408AN: 1458198Hom.: 279282 Cov.: 36 AF XY: 0.608 AC XY: 441264AN XY: 725280
GnomAD4 genome AF: 0.503 AC: 76463AN: 152000Hom.: 21691 Cov.: 31 AF XY: 0.501 AC XY: 37218AN XY: 74304
ClinVar
Submissions by phenotype
not specified Benign:4
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 21, 2013 | Asn2634Ser in exon 48 of DNAH11: This variant is not expected to have clinical s ignificance because it has been identified in 36.6% (3021/8252) of European Amer ican chromosomes from a broad population by the NHLBI Exome Sequencing Project ( http://evs.gs.washington.edu/EVS; dbSNP rs9639393). - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Primary ciliary dyskinesia Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Primary ciliary dyskinesia 7 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 10, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at